Suppliers / Matrix Laboratories

Matrix Laboratories

India Updated 9 July 2026

Matrix Laboratories is an API manufacturer based in India. It appears in 30 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and DAV (Vietnam). Customs aggregates show $9.1M of exports covering 224 molecules to 33 destinations in 2025.

0
active US DMFs
0
valid CEPs
0
registered plants
30
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Monelukast SFDA (Saudi Arabia) 2
Amlodipine SFDA (Saudi Arabia) 1
Gabapentin SFDA (Saudi Arabia) 1
Pregabalin SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Monelukast API Amlodipine API Gabapentin API Pregabalin API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 22 None
DAV (Vietnam) 8 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $3.8M 21
2025 Not reported $9.1M 33

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Matrix Laboratories

Does Matrix Laboratories hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Matrix Laboratories. It does have 30 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
What does Matrix Laboratories make?
4 molecules are on record against Matrix Laboratories, including Monelukast, Amlodipine, Gabapentin and Pregabalin. Each links through to that molecule's full manufacturer list.
Where does Matrix Laboratories file?
Filings are on record with US FDA and DAV (Vietnam), 30 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Matrix Laboratories?

Ask Fred what the record holds on Matrix Laboratories, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Open risk flags

  • 18 active litigation matters are on record.

Comparable suppliers

Hetero shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Macleods Pharmaceuticals shares 1 molecule Apotex shares 1 molecule Unimark Remedies shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts